December 9th, 2010
Obama’s Food and Drug Administration (FDA) is due to take up the case of Avastin, a cancer drug that successfully treats some 17,000 women annually. With a coming December 17 decision, the FDA seems poised to take this drug away from these patients quite despite the fact that their doctors find the drug effective.
The most dangerous period of time in Washington D.C. is that time we call the lame duck session (I call it the zombie congress; dead men walking). It is that time when those elected officials that are about to be ingloriously shipped off home for the last time due to losing election results make a mad scramble to grab for as much as they can get.
In the case of regulatory agencies like the FDA the lame duck session is not treated in exactly the same manner, but it is sure that when congress is about to have its majority party change over with the president’s party on the losing side of the switch, regulatory agencies often try to push through favored policies before the new congress is seated and before that new congress is in a position to put any pressure on those agencies to prevent them from pushing the president’s agenda.